Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Get the latest Replimune Group, Inc. (REPL) stock news and headlines to help you in your trading and investing decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback